Rick Mullin

发表

NEW MANAGEMENT: Private equity firms are investing in the RISKY BUSINESS of fine and pharmaceutical chemical manufacturing

Rick Mullin, 2010 .

MERCK'S VIOXX WOES SNOWBALL

Rick Mullin, 2004 .

ISOCHEM UPS ITS GAME

Rick Mullin, 2004 .

BMS will sell Ireland plant to SK

Rick Mullin, 2017 .

SUSTAINABLE SPECIALTIES: Performance chemical producers put renewable resources to the test as products of the future

Rick Mullin, R. Mullin, 2004 .

Swords or Plowshares

Rick Mullin, 2004, Science.

The Mind And Soul Of Science

Rick Mullin, 2006 .

Lilly spreads out in New York City

Rick Mullin, 2017 .

BALANCE OF POWER

Rick Mullin, 2004 .

NOVARTIS BIDS FOR ALL OF CHIRON

Rick Mullin, 2005 .

BILL NYE: The former TV 'SCIENCE GUY' is a self-proclaimed nerd on a mission

Rick Mullin, 2007 .

Scientific searches for dragon’s blood and the perfect burrito

Rick Mullin, 2016 .

TEXAS WEATHERS IKE: STORM ASSESSMENT: Many chemical plants, institutions remain shut

Elizabeth Wilson, Rick Mullin, 2008 .

NEW NOVARTIS CUTS TARGET 2,500 JOBS

Rick Mullin, 2007 .

UCB TO ACQUIRE SCHWARZ PHARMA: Multi-billion-dollar purchase continues European drug industry consolidation

Rick Mullin, 2006 .

AGC buys drug chemical plant in Spain

Rick Mullin, 2018 .

Behind the EpiPen

Rick Mullin, 2016 .

Biotech Rolled On The Charles

Rick Mullin, 2016 .

MAKING MORE IN AMERICA: CAMBRIDGE MAJOR is moving up to commercial-scale production of active pharmaceutical ingredients

Rick Mullin, 2008 .

DSM SCALES BACK

Rick Mullin, 2006 .

Cultural change in the Midwest

Rick Mullin, 2018 .

Pfizer offers a ‘green’ progesterone

Rick Mullin, 2018 .

MANUFACTURING Lilly restructures insulin and chemicals operation

Rick Mullin, 2007 .

CPHI PROMISES A HIGH-TECH COMEBACK

Rick Mullin, 2005 .

Pharmaceuticals: GSK clinches $3.6 billion deal for Human Genome Sciences

Rick Mullin, 2013 .

PFIZER UNVEILS BIG REVAMPING, JOB CUTS

Rick Mullin, 2007 .

European drug chemical makers active

Rick Mullin, 2018 .

LEARNING TO SHARE IN THE LAB: Electronic notebooks are opening minds in medicinal chemistry

Rick Mullin, 2003 .

ICAHN BOOSTS BIOTECH ACTIVITY: ACQUISITIONS: Dealmaker moves on several fronts to shake up the drug industry

Rick Mullin, 2008 .

UNCOMFORTABLE ISSUES IN 'PHALLACY': Carl Djerassi's play exposes bias among the DUELING TRIBES of science and the humanities

Rick Mullin, 2007 .

PHARMACEUTICAL CHEMICALS Dowpharma sells its U.K. operations to India’s Dr. Reddy’s

Rick Mullin, 2008 .

BIRD FLU ANGST

Rick Mullin, 2005 .

Contract drugmakers invest in dosage form

Rick Mullin, 2016 .

Rohm And Haas Study Clears Research Facility

Rick Mullin, 2004 .

Fine Chemicals BASF to sell custom synthesis and API businesses to Siegfried

Rick Mullin, 2016 .

BREAKTHROUGHS IN SPANISH BIOTECH: PHARMAMAR AND GENETRIX score in a sector of reticent investors and business-resistant academics

Rick Mullin, 2009 .

Avista buys into solid-state services

Rick Mullin, 2018 .

Off the drawing board

Rick Mullin, 2019 .

Olon, on a roll, adds generics in India

Rick Mullin, 2018 .

RHODIA CONSOLIDATES IN THE GARDEN STATE

Rick Mullin, 2004 .

MERCK SELLS LAB SUPPLY BUSINESS

Rick Mullin, 2004 .

Avara buys another drug formulation site

Rick Mullin, 2017 .

SPOTLIGHT ON DRUG RESEARCH: INNOVATION: Meeting attendees ponder routes to better quality drug candidates

Rick Mullin, 2007 .

BASF To Acquire Switzerland's Orgamol

Linda Wang, Rick Mullin, William Schulz, 2005 .

Cambrex expands its Swedish plant

Rick Mullin, 2017 .

CordenPharma, GE form oligonucleotide services pact

Rick Mullin, 2017 .

MAKING THE NEXT MOVE

Rick Mullin, 2004 .

China to dominate the radar in pharmaceutical services

Rick Mullin, 2019 .

Pharma in flux

Rick Mullin, 2006 .

NEXT BIG THING AT INFORMEX

Rick Mullin, 2005 .

GE readies biotech park in Ireland

Rick Mullin, 2016 .

PFIZER TAPS INCYTE FOR COMPOUNDS

Rick Mullin, 2005 .

A NEW BATTLEFIELD IN BIOLOGICS

Rick Mullin, 2004 .

Fertilizer Producers Exit Ammonium Nitrate

Rick Mullin, 2005 .

NEW LINES DRAWN AT CHEMSPEC EUROPE: Exhibitors have segregated fine and specialties oprations, but both sectors still matter

Rick Mullin, 2006 .

Dow, 1QBit join for quantum computing

Rick Mullin, 2017 .

STREAMLINING UTAH'S POPULATION DATABASE

Rick Mullin, 2005 .

Drug firms pick contract providers

Rick Mullin, 2018 .

JOHNSON MATTHEY BUILDS UP PHARMA: Pharm-Eco and Macfarlan Smith add new dimensions to a platinum-based API operation

Rick Mullin, 2003 .

RECALIBRATING THE CLINIC: High-tech tools and streamlined business processes are making their way to the far reaches of the drug development pipeline

Rick Mullin, 2005 .

PFIZER TO BUY VICURON

Rick Mullin, 2005 .

INSIGHTS: Seeing The Forest At PfizerA radical KNOWLEDGE-SHARING INITIATIVE takes hold at the world's largest drugmaker

Rick Mullin, 2007 .

The good times keep rolling in pharmaceutical chemicals

Rick Mullin, 2018 .

Platform Specialty Products launches as Element Solutions

Rick Mullin, 2019 .

FDA Advisers Deal Setbacks To Two Cancer Drugs

Rick Mullin, 2004 .

SIGMA-ALDRICH'S NEW FIVE-YEAR PLAN

Rick Mullin, 2006 .

Pharmacopeia Set To Split In Two

Rick Mullin, 2004 .

Costly Setbacks For Big Pharma

Rick Mullin, 2013 .

INFORMEX LOOKS AT EARLY PIPELINE

Michael Mccoy, Rick Mullin, 2004 .

AVENTIS, AMGEN INK PRICEY DEALS: Licensing remains a key strategy in the race to stoke pipelines

Rick Mullin, 2003 .

LATE IS GOOD IN CONTRACT PHARMA: With loss of early-stage drug-manufacturing business, CPhI exhibitors vie for LATE-STAGE OPPORTUNITIES

Rick Mullin, 2009 .

A Glimmer In Madrid

Rick Mullin, 2013 .

MINDING THE GAPS: Almac weaves its five divisions into a DRUG DEVELOPMENT services network

Rick Mullin, 2008 .

Optimism reigned at drug conference

Rick Mullin, 2017 .

Drug industry strength to buoy fine chemicals makers

Rick Mullin, 2018 .

Body Count: What if they had a GENOMICS REVOLUTION and nobody showed up?

Rick Mullin, 2008 .

NEW TURF FOR NANOFILTRATION

Rick Mullin, 2004 .

Cerbios opens Swiss R&D center

Rick Mullin, 2016 .

RECONNECTING TO SCIENCE: Pharma research conference looks beyond the 'blockbuster' business model

Rick Mullin, 2006 .

INDUSTRIAL BIOTECH AT THE BOTTOM LINE

Rick Mullin, 2004 .

Alnylam IPO Joins List Of Biotech Disappointments

Rick Mullin, 2004 .

WHAT'S THAT STUFF?

Rick Mullin, 2003 .

Dealing with data overload

Rick Mullin, 2004 .

FINDING PCAS: French fine chemicals firm hopes to show up on pharma industry radar industry radar after a wave of acquisitions

Rick Mullin, 2005 .

RESEARCH New firm to sell a polymer chip that emulates human physiology

Rick Mullin, 2015 .

The Patient Ascendant: A NEW HEALTH CARE ORDER is emerging, fueled by genetics and information

Rick Mullin, R. Mullin, 2010 .

LAB-TO-MARKET CONNECTION: SPECIALTY CHEMICAL COMPANIES try to ward off commoditization of their products with a mix of marketing, formulation, and basic R&D

Rick Mullin, 2008 .